Regulation by beta-adrenoceptor subtypes of cardiac function : Analysis by selective beta agonists

β-肾上腺素受体亚型对心脏功能的调节:选择性β激动剂的分析

基本信息

  • 批准号:
    02454485
  • 负责人:
  • 金额:
    $ 4.03万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1990
  • 资助国家:
    日本
  • 起止时间:
    1990 至 1991
  • 项目状态:
    已结题

项目摘要

This study was aimed to establish T-0509, the catechol derivative of denopamine, as selective beta_1 full agonist and to study functional significance of beta-adrenoceptor subtypes in the ventricular muscle of the heart using selective beta agonists.First we established the catechol derivative of denopamine (T-0509) as a selective beta_1 full agonist using isolated tissues and radioligand binding assay. T-0509 is almost as potent as isoproterenol and 150 times more selective to beta_1-adrenoceptors than beta_2- adrenoceptors as compared with isoproterenol.Following results were obtained using T-0509. (1) In the guinea pig heart, we found a subcellular fraction of cAMP which closely relates to the positive inotropic effects (PIE) of various cAMP-dependent agents. In this fraction, A kinase activity also closely related to PIE. (2) In the guinea pig ventricular muscle, PIE of beta full agonists can be explained by an increase in Ca^<2+> current via beta_1-adrenoceptors. (3) The beta full agonist causes desensitization by chronic administration to rats, but the doses used in previous studies were found to be extremely high to study the influence of beta-adrenoceptor subtypes in vivo. We are studying the possibility that selective beta_1 agonist causes weak desensitization as compared with non-selective beta agonists. (4) The beta-adrenoceptor has been shown in canine coronary artery. Wefound the possibility that beta_1 full agonist causes small but significant coronary vasodilation via beta_1-adrenoceptors even in the physiological condition.
这项研究的目的是建立T-0509,即beta_1的beta_1完全激动剂,并研究β-肾上腺素受体亚型在心脏的心室肌肉中的功能意义,使用选择性β激动剂。首先,我们建立了denopitivate denopitivate denopitivate denopitivate denoptivative denopitive denopativate denopativate denopativate t-10509)和放射性结合测定法。与异丙肾上腺素相比,T-0509几乎与异丙肾上腺素一样有效,对β_1-肾上腺素受体的选择性高150倍,对β_2-肾上腺素受体的选择性高出150倍。使用T-0509获得了遵循的结果。 (1)在豚鼠心脏中,我们发现了cAMP的亚细胞分数,与各种cAMP依赖性剂的阳性肌力作用(PIE)紧密相关。在此部分,激酶活性也与PIE密切相关。 (2)在豚鼠的心室肌肉中,可以通过通过beta_1- adenrenoceptors的Ca^<2+>电流增加来解释Beta全动力学家的馅饼。 (3)Beta完全激动剂会导致慢性给药对大鼠的脱敏,但发现先前研究中使用的剂量非常高,以研究β-肾上腺素粘膜亚型在体内的影响。我们正在研究与非选择性β激动剂相比,选择性β_1激动剂会导致弱脱敏的可能性。 (4)β-肾上腺素受体已显示在犬冠状动脉中。 beta_1完全激动剂也可能通过beta_1-肾上腺素受体引起小但显着的冠状动脉血管舒张的可能性,即使在生理状态下也是如此。

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T.Sugimoto,H.Yabana,J.Yamazaki&T.Nagao: "The role of β-adrenoceptor subtypes on coronary blood flow in anesthetized open-chest dogs." Japanese Journal of Pharmacology. 55. 332 (1991)
T.Sugimoto、H.Yabana、J.Yamazaki 和 T.Nagao:“β-肾上腺素受体亚型对麻醉开胸犬冠状动脉血流的作用”,《日本药理学杂志》55. 332 (1991)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H.Yabana;H.Watanabe;H.Narita;T.Nagao: "Selective and full β_1ーadrenoceptor agonist action of a catechol derivative of denopamine(Tー0509)in the guinea pig candiac muscle and trachea:comparison with denopamine,xamolerol and isoprenaline" British Journal of
H.Yabana;H.Watanabe;H.Narita;T.Nagao:“地诺帕明儿茶酚衍生物 (T-0509) 对豚鼠念珠肌和气管的选择性和完全 β_1-肾上腺素能受体激动作用:与地诺帕明、沙莫罗尔的比较和异丙肾上腺素”英国杂志
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Sugimoto;H.Yabana;J.Yamazaki;T.Nagao: "The role of βーadrenoceptor subtypes on coronary blood flow in anesthetized openーchest clogs" Japanese Journal of Pharmacology. 55. 332 (1991)
T.Sugimoto;H.Yabana;J.Yamazaki;T.Nagao:“β-肾上腺素受体亚型对麻醉开胸木屐中冠状动脉血流的作用”《日本药理学杂志》55. 332 (1991)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H.Narita,M.Gaino T.Suzuki,T.Nagao: "Synthesis and Pharmacological Properties of Azido Derivatives of 1.5ーBenzothiazepine Ca Antagonist" Chem.Pharm.Bull.38. 407-410 (1990)
H.Narita,M.Gaino T.Suzuki,T.Nagao:“1.5-苯并硫氮卓 Ca 拮抗剂的叠氮衍生物的合成和药理学特性”Chem.Pharm.Bull.38 (1990)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Nagao: "Pharmacological properties and mechanism of action of denopamine in experimental animals" <In>___ー Heart FailureーMechanisms and Management.B,S,Lewis and A.Kimchi (Eds) SpringerーVerlag Berlin. 211-218 (1991)
T.Nagao:“实验动物中地诺巴明的药理学特性和作用机制”<In>___-心力衰竭-机制和管理。B、S、Lewis 和 A.Kimchi(编辑)Springer-Verlag Berlin 211-218( 1991)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAGAO Taku其他文献

NAGAO Taku的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAGAO Taku', 18)}}的其他基金

Novel Therapeutic Strategy for Heart Failure : Molecular Mechanism underlying the Regulation of Ca^<2+> Signaling in the Heart
心力衰竭的新治疗策略:心脏中 Ca^<2> 信号传导调节的分子机制
  • 批准号:
    13307065
  • 财政年份:
    2001
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Role of receptor kinase in β1-adrenergic receptor signaling, and hypertrophy/heart failure
受体激酶在 β1-肾上腺素能受体信号传导和肥厚/心力衰竭中的作用
  • 批准号:
    11557189
  • 财政年份:
    1999
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Study on regulatory mechanism for cardiac contraction : seeking for therapeutic basis of heart failure.
心脏收缩调节机制的研究:寻找心力衰竭的治疗基础。
  • 批准号:
    10307056
  • 财政年份:
    1998
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).
Establishment of Functional Analysis by Expressing Antibody Molecule in the Cells
细胞内表达抗体分子功能分析的建立
  • 批准号:
    07557151
  • 财政年份:
    1995
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of effects of Ca-antagonists in pathophysiological models
Ca2+拮抗剂在病理生理模型中的作用分析
  • 批准号:
    04454530
  • 财政年份:
    1992
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了